SAGE's Cookie Policy
Close 

To enhance your experience on our site, SAGE stores cookies on your computer. By continuing you consent to receive cookies.

Learn More

Journal of the Renin-Angiotensin-Aldosterone System

(Including Other Peptidergic Systems)

Editors in Chief:
London, UK
US Editor:
Washington DC, USA
Executive Editor:
Imperial College London, London, UK
 
2011 Impact Factor: 2.439
2011 Ranking: 32/68 in Peripheral Vascular Disease
Source: 2011 Journal Citation Reports ® (Thomson Reuters, 2012)

Journal of the Renin-Angiotensin-Aldosterone System (JRAAS) is a peer-reviewed journal published quarterly as a resource for biomedical professionals, including basic scientists and clinicians, primarily with an active interest in the renin-angiotensin-aldosterone system in humans and other mammals.

It publishes original research articles and reviews on the normal and abnormal function of this system and its pharmacology and therapeutics, mostly in a cardiovascular context but including research in all areas where this system is present, including the brain, lungs and gastro-intestinal tract.

Although this is its main focus, JRAAS also publishes research on other peptides, such as vasopressin, the natriuretic peptides and the kallikrein-kinin system.

 

Subscription Information:
Institutional Subscription, Combined (Print & E-access) £271.00
Individual Subscription, Combined (Print & E-access) £156.00

To purchase a non-standard subscription or a back issue, please contact SAGE Customer Services for availability.
subscriptions@sagepub.co.uk +44 (0) 20 7324 8701

Institutional, Single Print Issue £75.00
Individual, Single Print Issue £51.00
Frequency: Quarterly eISSN: 1752-8976 ISSN: 1470-3203
Months of Distribution: March , June , September , December Current Volume: 14 Current Issue: 1
Other Titles in: Cardiology & Cardiovascular Medicine  |  Diabetes

Product Type

All

Subject Areas

All